학술논문
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy
Document Type
Article
Author
Wagner, N.B.; Cozzio, A.; Flatz, L.; Lenders, M.M.; Amaral, T.; Forschner, A.; Leiter, U.; Garbe, C.; Eigentler, T.K.; Kühl, K.; Reinhardt, L.; Meier, F.; Fuchß, M.; Loquai, C.; Ring, N.; Stäger, R.; Mangana, J.; Zellweger, C.; Ebel, C.; Terheyden, P.; Kimeswenger, S.; Oellinger, A.; Hoetzenecker, W.; Klumpp, B.
Source
In: European Journal of Cancer . (European Journal of Cancer, January 2024, 196)
Subject
Language
English
ISSN
18790852
09598049
09598049